Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine
Valentin Van den Bossche, Hannah Zaryouh, Marianela Vara-Messler, et al.
Drug Resistance Updates (2022) Vol. 60, pp. 100806-100806
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Targeted therapy for head and neck cancer: signaling pathways and clinical studies
Qingfang Li, Yan Tie, Aqu Alu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 113
Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes
Huai Liu, Ling Tang, Yanxian Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 29
Artificial intelligence-based prediction of clinical outcome in immunotherapy and targeted therapy of lung cancer
Xiaomeng Yin, Hu Liao, Yun Hong, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 146-159
Closed Access | Times Cited: 58
Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma
Manfei Pi, Huixian Kuang, Chunyan Yue, et al.
Drug Resistance Updates (2022) Vol. 61, pp. 100822-100822
Closed Access | Times Cited: 53
Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment
Junnan Li, Lipeng Zhu, Hang Fai Kwok
Drug Resistance Updates (2022) Vol. 66, pp. 100904-100904
Closed Access | Times Cited: 48
The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications
Philippe Icard, Luca Simula, Ludovic Fournel, et al.
Drug Resistance Updates (2022) Vol. 63, pp. 100852-100852
Open Access | Times Cited: 39
Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma: opportunities and challenges
Hu Chen, Yifan Zhang, Chunping Wu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 25
IL-8 activates fibroblasts to promote the invasion of HNSCC cells via STAT3-MMP1
Yu Chen, Li Huang, Rui-Huan Gan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 10
The Role of Biomarkers in HPV-Positive Head and Neck Squamous Cell Carcinoma: Towards Precision Medicine
Antea Kršek, Lara Batičić, Vlatka Sotošek Tokmadžić, et al.
Diagnostics (2024) Vol. 14, Iss. 13, pp. 1448-1448
Open Access | Times Cited: 10
Innate immune cells: Key players of orchestra in modulating tumor microenvironment (TME)
Mahvash Sadeghi, Sajad Dehnavi, Moosa Sharifat, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27480-e27480
Open Access | Times Cited: 9
Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis
Juan P. Rodrigo, Mario Sánchez‐Canteli, María Otero‐Rosales, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways
Dengxiong Li, Fanglin Shao, Qingxin Yu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response
Habib Sadeghirad, James Monkman, Chin Wee Tan, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma
Hanqi Wang, Ruxing Fu, Qi‐Wen Man, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2173-2173
Open Access | Times Cited: 17
Serum Albumin as an Independent Predictor of Long-Term Survival in Patients with Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab
Shinsuke Suzuki, Yukie Taguchi, Takuro Kitabayashi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2456-2456
Open Access | Times Cited: 6
A PANoptosis pattern to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma
Feng Gao, Minghuan Zhang, Zhenguang Ying, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27162-e27162
Open Access | Times Cited: 5
Understanding the Dual Role of Macrophages in Tumor Growth and Therapy: A Mechanistic Review
Muhammad Summer, Saima Riaz, Shaukat Ali, et al.
Chemistry & Biodiversity (2025)
Closed Access
PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma
Valentin Van den Bossche, Julie Vignau, Engy Vigneron, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Identification of exosome-related genes associated with prognosis and immune infiltration features in pancreatic cancer
Jie Wang, Min Qing, Jie Gui, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Nanozyme-Based Strategies in Cancer Immunotherapy: Overcoming Resistance to Enhance Therapeutic Efficacy
Guangjian Hou, Yukun Xu, Chunhua Wang, et al.
Aging and Disease (2025)
Open Access
Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance
Lin Xu, Qingyi Zhang, Qi Li, et al.
Drug Resistance Updates (2023) Vol. 73, pp. 101032-101032
Open Access | Times Cited: 14
TIPE3 represses head and neck squamous cell carcinoma progression via triggering PGAM5 mediated mitochondria dysfunction
Wei Chen, Xijuan Chen, Lixuan Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 13
Global trends of single cell sequence associated in cancer from 2011 to 2024: A bibliometric analysis
Xueliang Wu, Jianchun Fan, Xingmei Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32847-e32847
Open Access | Times Cited: 4
Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells
Nina Klieber, Laura S. Hildebrand, Eva Faulhaber, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 304-304
Open Access | Times Cited: 3
Engineering models of head and neck and oral cancers on-a-chip
Maurício Gonçalves da Costa Sousa, Sofia M. Vignolo, Cristiane Miranda França, et al.
Biomicrofluidics (2024) Vol. 18, Iss. 2
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top